Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 23

Sort by

Sort Order Select

Journal Articles

Patients' Perception of Usability and Utility of a Digital Health Tool for Electronic Patient-Reported Outcomes Monitoring in Real-Life Hematology Practice: Evidence from the Gimema-Alliance Platform

Blood (2023) 142 (Supplement 1): 3714.

https://doi.org/10.1182/blood-2023-180574

Published: 2023

Journal Articles

The Unique BCR Inhibiting Properties of BMS-986205 in Chronic Lymphocytic Cells

Claudio Giacinto Atene, Stefania Fiorcari, Nicolò Mesini, Rossana Maffei, Silvia Martinelli, Flora Pilato, Monica Maccaferri, Leonardo Potenza, Mario Luppi, Roberto Marasca

Blood (2023) 142 (Supplement 1): 6516.

https://doi.org/10.1182/blood-2023-189127

Published: 2023

Journal Articles

Chromosome 9p Duplication Promotes T-Cell Exhaustion and Enhances Stem Cell Clonogenic Potential in JAK2-Mutant Myeloproliferative Neoplasms

Blood (2023) 142 (Supplement 1): 1780.

https://doi.org/10.1182/blood-2023-182420

Published: 2023

Journal Articles

Peripheral Blood Cytotoxic T Cells from Myelofibrosis Patients Show Early Exhausted Features Targetable By CTLA-4 Inhibition

Lara Tavernari, Sebastiano Rontauroli, Monica Maccaferri, Barbara Mora, Elia Venturelli, Elisa Bianchi, Sandra Parenti, Elena Genovese, Paola Guglielmelli, Chiara Carretta, Margherita Mirabile, Stefano Sartini, Corrado Colasante, Leonardo Potenza, Francesco Passamonti, Enrico Tagliafico, Mario Luppi, Alessandro M. Vannucchi, Rossella Manfredini

Blood (2022) 140 (Supplement 1): 9600–9601.

https://doi.org/10.1182/blood-2022-167161

Published: 2022

Journal Articles

Clinical Utility and Physician Perceptions of a Digital Platform for Electronic Patient-Reported Outcomes Monitoring in Patients with Hematologic Malignancies in Real-World Practice

Blood (2021) 138 (Supplement 1): 4017.

https://doi.org/10.1182/blood-2021-146508

Published: 2021

Journal Articles

The Accuracy of the International Myeloma Working Group Frailty Score in Capturing Health-Related Quality of Life Profile of Patients with Relapsed Refractory Multiple Myeloma

Blood (2021) 138 (Supplement 1): 115.

https://doi.org/10.1182/blood-2021-145977

Published: 2021

Journal Articles

Indoleamine 2,3-Dioxygenase Mediates Survival of Chronic Lymphocytic Leukemia B Cells through Aryl Hydrocarbon Receptor By Inducing Mcl1

Claudio Giacinto Atene, Rossana Maffei, Stefania Fiorcari, Silvia Martinelli, Patrizia Zucchini, Monica Maccaferri, Giulia Debbia, Leonardo Potenza, Mario Luppi, Roberto Marasca

Blood (2020) 136 (Supplement 1): 19.

https://doi.org/10.1182/blood-2020-142345

Published: 2020

Journal Articles

NOTCH2 Contributes to Venetoclax Resistance in Chronic Lymphocytic Leukemia

Stefania Fiorcari, PhD, Rossana Maffei, PhD, Claudio Giacinto Atene, PhD, Silvia Martinelli, Leonardo Potenza, Mario Luppi, MD, Roberto Marasca, MD

Blood (2019) 134 (Supplement_1): 4280.

https://doi.org/10.1182/blood-2019-128499

Published: 2019

Journal Articles

Interferon Regulatory Factor 4 Orchestrates the Response to B-Cell Receptor in Chronic Lymphocytic Leukemia Cells By Regulating Ikaros

Rossana Maffei, Stefania Fiorcari, PhD, Silvia Martinelli, Stefania Benatti, Patrizia Zucchini, Giulia Debbia, Leonardo Potenza, Mario Luppi, Roberto Marasca

Blood (2017) 130 (Supplement 1): 59.

https://doi.org/10.1182/blood.V130.Suppl_1.59.59

Published: 2017

Journal Articles

Seifem 2016 Study: Incidence of Probable and Proven Invasive Aspergillosis in Patients with Acute Myeloid Leukemia during Consolidation Therapy

Maria Ilaria Del Principe, Roberta di Blasi, MD, Luisa Verga, MD, Anna Candoni, MD, Stelvio Ballanti, MD, Leonardo Potenza, Chiara Cattaneo, MD, Mario Delia, MD, Nunzia Decembrino, MD, Lorella MA Melillo, MD, Carlo Castagnola, MD, Gianpaolo Nadali, MD, Rosa Fanci, MD, Antonella Ferrari, MD, Nicola Fracchiolla, MD, Enrico Orciuolo, PhD MD, Federica Lessi, MD, Anna Chierichini, MD, Massimo Offidani, MD, Marco Picardi, MD, Lucia Prezioso, MD, Benedetta Rambaldi, MD, Francesco Marchesi, MD, Ombretta Annibali, Daniele Zama, MD, Valentina Mancini, MD, Prassede Salutari, MD, Maria Grazia Garzia, MD, Adriana Vacca, MD, Simone Cesaro, MD, Rosangela Invernizzi, MD, Katia Perruccio, MD, Maria Enza Mitra, MD, Angela Maria Quinto, MD, Maria Chiara Tisi, Bruno Martino, Adriano Venditti, MD, Alessandro Busca, Franco Aversa, MD, Livio Pagano, MD

Blood (2017) 130 (Supplement 1): 5018.

https://doi.org/10.1182/blood.V130.Suppl_1.5018.5018

Published: 2017

Journal Articles

Interferon Regulatory Factor 4 (IRF4) Is a Master Regulator in the Pathogenesis of Chronic Lymphocytic Leukemia Patients Harboring Trisomy 12

Stefania Fiorcari, PhD, Stefania Benatti, Silvia Martinelli, Patrizia Zucchini, Giovanna Leonardi, Leonardo Potenza, Mario Luppi, Roberto Marasca, Rossana Maffei

Blood (2017) 130 (Supplement 1): 4305.

https://doi.org/10.1182/blood.V130.Suppl_1.4305.4305

Published: 2017

Journal Articles

BCR-ABL–specific T-cell therapy in Ph + ALL patients on tyrosine-kinase inhibitors

Blood (2017) 129 (5): 582–586.

https://doi.org/10.1182/blood-2016-07-731091

Published: 2017

Includes: Supplemental data

Journal Articles

Invasive Fungal Infections in Acute Promyelocytic Leukemia Patients. Results of a Prospective Multicenter Study in Italy

Blood (2014) 124 (21): 3682.

https://doi.org/10.1182/blood.V124.21.3682.3682

Published: 2014

Journal Articles

Lenalidomide Promotes a Pro-Inflammatory Switch of Nurse-like Cells Derived from Chronic Lymphocytic Leukemia

Rossana Maffei, Stefania Fiorcari, Silvia Martinelli, Jenny Bulgarelli, Valentina Audrito, Patrizia Zucchini, Giulia Debbia, Elisabetta Colaci, Leonardo Potenza, Franco Narni, Silvia Deaglio, Mario Luppi, Roberto Marasca

Blood (2014) 124 (21): 3286.

https://doi.org/10.1182/blood.V124.21.3286.3286

Published: 2014

Journal Articles

How I treat HHV8/KSHV-related diseases in posttransplant patients

Giovanni Riva, Mario Luppi, Patrizia Barozzi, Fabio Forghieri, Leonardo Potenza

Blood (2012) 120 (20): 4150–4159.

https://doi.org/10.1182/blood-2012-04-421412

Published: 2012

Journal Articles

Protective T-Cell Responses to Several Recombinant Aspergillus Antigens May Be Detected Since the Onset of the Infection in Patients with Invasive Aspergillosis, and May Be Exploited for Therapeutic Purposes,

Blood (2011) 118 (21): 3229.

https://doi.org/10.1182/blood.V118.21.3229.3229

Published: 2011

Journal Articles

Drug Resistance and Bcr-Abl Kinase Domain Mutations In Philadelphia-Positive Acute Lymphoblastic Leukemia From the Imatinib to the 2 nd -Generation Tyrosine Kinase Inhibitor Era: The Main Changes Are In the Type of Mutations, but Not In the Frequency of Mutation Involvement

Blood (2011) 118 (21): 575.

https://doi.org/10.1182/blood.V118.21.575.575

Published: 2011

Journal Articles

Mucorales -specific T cells emerge in the course of invasive mucormycosis and may be used as a surrogate diagnostic marker in high-risk patients

Blood (2011) 118 (20): 5416–5419.

https://doi.org/10.1182/blood-2011-07-366526

Published: 2011

Includes: Supplemental data

Journal Articles

Use of a High Sensitive Nanofluidic Array for the Detection of Rare Copies of BCR-ABL1 Transcript In Patients with Philadelphia-Positive Acute Lymphoblastic Leukemia (ALL).

Ilaria Iacobucci, Annalisa Lonetti, Anna Ferrari, Cristina Papayannidis, Simona Soverini, Stefania Paolini, Mariachiara Abbenante, Viviana Guadagnuolo, Sarah Parisi, Leonardo Potenza, Mario Luppi, Federica Cattina, Domenico Russo, Fabrizio Pane, MD, Michele Baccarani, Giovanni Martinelli

Blood (2010) 116 (21): 1677.

https://doi.org/10.1182/blood.V116.21.1677.1677

Published: 2010

Journal Articles

Emergence of BCR-ABL–specific cytotoxic T cells in the bone marrow of patients with Ph + acute lymphoblastic leukemia during long-term imatinib mesylate treatment

Giovanni Riva, Mario Luppi, Patrizia Barozzi, Chiara Quadrelli, Sabrina Basso, Daniela Vallerini, Eleonora Zanetti, Monica Morselli, Fabio Forghieri, Monica Maccaferri, Francesco Volzone, Cinzia Del Giovane, Roberto D'Amico, Franco Locatelli, Giuseppe Torelli, Patrizia Comoli, Leonardo Potenza

Blood (2010) 115 (8): 1512–1518.

https://doi.org/10.1182/blood-2009-06-230391

Published: 2010

NARROW

Patients' Perception of Usability and Utility of a Digital Health Tool for Electronic Patient-Reported Outcomes Monitoring in Real-Life Hematology Practice: Evidence from the Gimema-Alliance Platform

The Unique BCR Inhibiting Properties of BMS-986205 in Chronic Lymphocytic Cells

Chromosome 9p Duplication Promotes T-Cell Exhaustion and Enhances Stem Cell Clonogenic Potential in JAK2-Mutant Myeloproliferative Neoplasms

Peripheral Blood Cytotoxic T Cells from Myelofibrosis Patients Show Early Exhausted Features Targetable By CTLA-4 Inhibition

Clinical Utility and Physician Perceptions of a Digital Platform for Electronic Patient-Reported Outcomes Monitoring in Patients with Hematologic Malignancies in Real-World Practice

The Accuracy of the International Myeloma Working Group Frailty Score in Capturing Health-Related Quality of Life Profile of Patients with Relapsed Refractory Multiple Myeloma

Indoleamine 2,3-Dioxygenase Mediates Survival of Chronic Lymphocytic Leukemia B Cells through Aryl Hydrocarbon Receptor By Inducing Mcl1

NOTCH2 Contributes to Venetoclax Resistance in Chronic Lymphocytic Leukemia

Interferon Regulatory Factor 4 Orchestrates the Response to B-Cell Receptor in Chronic Lymphocytic Leukemia Cells By Regulating Ikaros

Seifem 2016 Study: Incidence of Probable and Proven Invasive Aspergillosis in Patients with Acute Myeloid Leukemia during Consolidation Therapy

Interferon Regulatory Factor 4 (IRF4) Is a Master Regulator in the Pathogenesis of Chronic Lymphocytic Leukemia Patients Harboring Trisomy 12

BCR-ABL–specific T-cell therapy in Ph + ALL patients on tyrosine-kinase inhibitors

Invasive Fungal Infections in Acute Promyelocytic Leukemia Patients. Results of a Prospective Multicenter Study in Italy

Lenalidomide Promotes a Pro-Inflammatory Switch of Nurse-like Cells Derived from Chronic Lymphocytic Leukemia

How I treat HHV8/KSHV-related diseases in posttransplant patients

Protective T-Cell Responses to Several Recombinant Aspergillus Antigens May Be Detected Since the Onset of the Infection in Patients with Invasive Aspergillosis, and May Be Exploited for Therapeutic Purposes,

Drug Resistance and Bcr-Abl Kinase Domain Mutations In Philadelphia-Positive Acute Lymphoblastic Leukemia From the Imatinib to the 2 nd -Generation Tyrosine Kinase Inhibitor Era: The Main Changes Are In the Type of Mutations, but Not In the Frequency of Mutation Involvement

Mucorales -specific T cells emerge in the course of invasive mucormycosis and may be used as a surrogate diagnostic marker in high-risk patients

Use of a High Sensitive Nanofluidic Array for the Detection of Rare Copies of BCR-ABL1 Transcript In Patients with Philadelphia-Positive Acute Lymphoblastic Leukemia (ALL).

Emergence of BCR-ABL–specific cytotoxic T cells in the bone marrow of patients with Ph + acute lymphoblastic leukemia during long-term imatinib mesylate treatment

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only